Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Article Type
Facet Toggle
Event Type
Facet Toggle
Time Frame
Facet Toggle
Time Frame
Facet Toggle
WORKING PAPERS
January 29, 2025
This study estimates the costs of four key interventions to mitigate antimicrobial resistance globally by 2050. These interventions include improving access to water, sanitation, and hygiene, enhancing childhood vaccination, developing new antibiotics, and increasing access to healthcare and existin...
WORKING PAPERS
January 29, 2025
This study estimates the global inpatient healthcare costs attributable to antimicrobial resistance (AMR) and projects future expenditures across different scenarios. It finds that AMR accounts for 25.4 million hospital admissions annually, resulting in $66.4 billion in excess healthcare costs, with...
WORKING PAPERS
January 29, 2025
Antimicrobial resistance (AMR) poses a major global challenge, affecting both human health and economies. This research models the potential impacts of AMR on global GDP and various sectors, showing that while better treatment and combined interventions can boost economic growth, accelerated resista...
Blog Post
January 22, 2025
In 2021 alone, AMR killed an estimated 1.14 million people annually—and if countries stick to a business-as-usual approach, it could claim 39 million lives between 2025 and 2050. Beyond the human toll, rising resistance rates could drive health costs up by US$ 325 billion and shrink the global econo...
Blog Post
October 07, 2024
One of the main drivers of the problem of antimicrobial resistance (AMR)—an impending crisis which already causes over 1.25 million annual deaths globally and nearly 300,000 annual deaths in India—is the overuse of antibiotics. While access to antibiotics is key to prevent mortality, insufficient co...
BRIEFS
September 30, 2024
Antimicrobial resistance (AMR) is responsible for a large and growing burden of mortality, morbidity, and economic impacts. This is due to three underlying problems: lack of access to essential antimicrobials, insufficient stewardship of these drugs to prevent overuse and misuse, and a dearth of inn...
CGD NOTES
September 05, 2024
Access to effective antimicrobials is crucial to any healthcare system, but in many countries, necessary antimicrobials are not available to patients because they have not been registered and/ or introduced. This introduction barrier is particularly prevalent in low- and middle-income countries (LMI...
Blog Post
March 13, 2024
When world leaders gather in September for this year’s UN General Assembly, antimicrobial resistance (AMR) will be on the agenda. For people like me who care passionately about this issue, this is a welcome opportunity to address a global problem with a global solution. Ahead of September, we need t...
Blog Post
February 22, 2024
The process of discovering, producing, buying, and consuming antibiotics is riddled with market and government failures. To solve antibiotic resistance, it’s not enough to solve just some of these. If we fix the market failures that reduce the number of new antibiotics that are discovered, but not t...